PD-L1 Immunohistochemistry for Non-Small Cell Lung Cancer on Cytology Specimens

被引：0
|
作者：
Banach, Bridget [1 ]
Antic, Tatjana [1 ]
Mueller, Jeffrey [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
MODERN PATHOLOGY | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
368
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [31] Comparison of PD-L1 Expression Between Preoperative Biopsy Specimens and Surgical Specimens in Non-Small Cell Lung Cancer
    Sakaguchi, Tadashi
    Iketani, Akemi
    Ito, Kentaro
    Nishii, Yoichi
    Katsuta, Koji
    Hataji, Osamu
    CANCERS, 2025, 17 (03)
  • [32] Comparison of PD-L1 immunohistochemistry assays for non-small-cell lung cancer
    Hong, Goohyeon
    Kim, Youn Seup
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [33] Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer
    Scheel, Andreas H.
    Baenfer, Gudrun
    Baretton, Gustavo
    Dietel, Manfred
    Diezko, Rolf
    Henkel, Thomas
    Heukamp, Lukas C.
    Jasani, Bharat
    Joehrens, Korinna
    Kirchner, Thomas
    Lasitschka, Felix
    Petersen, Iver
    Reu, Simone
    Schildhaus, Hans-Ulrich
    Schirmacher, Peter
    Schwamborn, Kristina
    Sommer, Ulrich
    Stoss, Oliver
    Tiemann, Markus
    Warth, Arne
    Weichert, Wilko
    Wolf, Juergen
    Buettner, Reinhard
    Rueschoff, Josef
    HISTOPATHOLOGY, 2018, 72 (03) : 449 - 459
  • [34] Cytology and Surgical Pathology Specimens are Comparable Testing Substrates for PD-L1 Immunohistochemistry in Lung Cancer
    Vanderlaan, P.
    Torous, V.
    Rangachari, D.
    Costa, D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1820 - S1820
  • [35] Multicentre study on the consistency of PD-L1 immunohistochemistry as predictive test for immunotherapy in non-small cell lung cancer
    Butter, Rogier
    't Hart, Nils A.
    Hooijer, Gerrit K. J.
    Monkhorst, Kim
    Speel, Ernst-Jan
    Theunissen, Paul
    Thunnissen, Erik
    Von der Thusen, Jan H.
    Timens, Wim
    van de Vijver, Marc J.
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (07) : 423 - 430
  • [36] Landscape of Biomarkers in Non-small Cell Lung Cancer Using Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry
    Huang, Richard S. P.
    Severson, Eric
    Haberberger, James
    Duncan, Daniel L.
    Hemmerich, Amanda
    Edgerly, Claire
    Ferguson, N. Lynn
    Frampton, Garrett
    Owens, Clarence
    Williams, Erik
    Elvin, Julia
    Vergilio, Jo-Anne
    Killian, Jonathan Keith
    Lin, Douglas
    Morley, Samantha
    McEwan, Deborah
    Holmes, Oliver
    Danziger, Natalie
    Cohen, Michael B.
    Sathyan, Pratheesh
    McGregor, Kimberly
    Reddy, Prasanth
    Venstrom, Jeffrey
    Anhorn, Rachel
    Alexander, Brian
    Brown, Charlotte
    Ross, Jeffrey S.
    Ramkissoon, Shakti H.
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [37] One centre experience in evaluation of PD-L1 immunohistochemistry staining in patients with non-small cell lung cancer
    Glumac, S.
    Jovanovic, M.
    Skodric, S. Radojevic
    Gacic, E. Manojlovic
    Tomanovic, N.
    Djurdjevic, B. Vukomanovic
    Dozic, B.
    Vucinic, V.
    VIRCHOWS ARCHIV, 2021, 479 : S295 - S295
  • [38] PD-L1 immunohistochemistry for non-small cell lung carcinoma: which strategy should be adopted?
    Hofman, Paul
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (12) : 1097 - 1108
  • [39] PD-1 and PD-L1 inhibitor toxicities in non-small cell lung cancer
    Shankar, Bairavi
    Naidoo, Jarushka
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S4034 - S4037
  • [40] Targeting the PD-1/PD-L1 axis in non-small cell lung cancer
    Kumar, Rajiv
    Collins, Dearbhaile
    Dolly, Saoirse
    McDonald, Fiona
    O'Brien, Mary E. R.
    Yap, Timothy A.
    CURRENT PROBLEMS IN CANCER, 2017, 41 (02) : 111 - 124
12345